NOS
INOSINE
Created: | 1999-07-08 |
Last modified: | 2018-09-13 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 31 |
Chiral Atom Count | 4 |
Bond Count | 33 |
Aromatic Bond Count | 5 |
Chemical Component Summary | |
---|---|
Name | INOSINE |
Systematic Name (OpenEye OEToolkits) | 9-[(2~{R},3~{R},4~{S},5~{R})-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]-1~{H}-purin-6-one |
Formula | C10 H12 N4 O5 |
Molecular Weight | 268.226 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | CACTVS | 3.385 | OC[CH]1O[CH]([CH](O)[CH]1O)n2cnc3C(=O)NC=Nc23 |
SMILES | OpenEye OEToolkits | 2.0.6 | c1nc2c(n1C3C(C(C(O3)CO)O)O)N=CNC2=O |
Canonical SMILES | CACTVS | 3.385 | OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3C(=O)NC=Nc23 |
Canonical SMILES | OpenEye OEToolkits | 2.0.6 | c1nc2c(n1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N=CNC2=O |
InChI | InChI | 1.03 | InChI=1S/C10H12N4O5/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18/h2-4,6-7,10,15-17H,1H2,(H,11,12,18)/t4-,6-,7-,10-/m1/s1 |
InChIKey | InChI | 1.03 | UGQMRVRMYYASKQ-KQYNXXCUSA-N |
Drug Info: DrugBank
DrugBank ID | DB04335 |
---|---|
Name | Inosine |
Groups |
|
Description | A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed) |
Synonyms |
|
Brand Names | Rejuvesol |
Indication | The primary popular claim made for inosine, that it enhances exercise and athletic performance, is refuted by the available research data. There is some preliminary evidence that inosine may have some neurorestorative, anti-inflammatory, immunomodulatory and cardioprotective effects. |
Categories |
|
ATC-Code |
|
CAS number | 58-63-9 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Purine nucleoside phosphorylase | MENGYTYEDYKNTAEWLLSHTKHRPQVAIICGSGLGGLTDKLTQAQIFDY... | unknown | |
IAG-nucleoside hydrolase | MAKNVVLDHDGNLDDFVAMVLLASNTEKVRLIGALCTDADCFVENGFNVT... | unknown | |
Purine nucleoside phosphorylase DeoD-type | MATPHINAEMGDFADVVLMPGDPLRAKYIAETFLEDAREVNNVRGMLGFT... | unknown | |
Xanthine dehydrogenase/oxidase | MTADKLVFFVNGRKVVEKNADPETTLLAYLRRKLGLSGTKLGCGEGGCGA... | unknown | substrate,inducer |
Solute carrier family 28 member 3 | MELRSTAAPRAEGYSNVGFQNEENFLENENTSGNNSIRSRAVQSREHTNT... | unknown |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 6021, 5274258, 135398641 |
ChEMBL | CHEMBL1556 |
ChEBI | CHEBI:17596 |
CCDC/CSD | INOSND10, INOSIN10, XEHKAA |